A study conducted in the United States has found that there is a very severe allergic reaction among Moderna COVID-19 vaccine recipients. According to the U.S. Center for Disease Control and Prevention, only 10 cases of severe allergic reactions were detected in Moderna COVID-19 vaccine recipients after more than 4 million first sightings between December 21 and January 10. The CDC reported that only 10 cases of Anaphylaxis have been detected in recipients, which is a life-threatening sensory reaction that rarely occurs after vaccination. At the same time, zero deaths were reported among Moderna’s COVID-19 vaccine recipients. CDC reported that nine out of the 10 allergic reactions were reported immediately after the vaccine was given, within 15 minutes of inoculation.
Read: COVID-19: Moderna says immunity created by its vaccine lasts a year
Moderna received an emergency use permit certificate for the COVID-19 vaccine from the U.S. Food and Drug Administration (FDA) on Dec. 18. The vaccine is a two – dose drug that needs to be administered 28 days apart. As of January 10, the U.S. government had introduced more than 4 million first-rate doses nationwide. The Vaccine Adverse Event Reporting System (VAERS) received 1,266 reports of adverse events following the Moderna vaccine, 108 of which were identified for review as potential cases of adverse allergic reactions. , including anaphylaxis. According to the CDC, only 10 cases were identified as anaphylaxis among the 108 cases of adverse reactions that may have been reported by VAERS. Of those 10 cases, nine had a recorded history of allergies or allergic reactions, five of whom had a previous history of anaphylaxis.
Read: Spain to receive first batch of Moderna COVID vaccine in 7-10 days, says Health Minister
Read: COVID-19: May Halve Moderna US vaccine doses to protect more people
US CDC changes guidelines
The U.S. CDC recently changed its vaccination guidelines allowing authorities to administer a second dose 42 days after the first injection, which they previously rejected a tweak citing a lack of data on the same. “The second dose should be administered in close proximity to the recommended time. However, if it is not possible to comply with the recommended interval, a second dose of Pfizer- BioNTech and Moderna recorded COVID-19 for administration up to 6 weeks (42 days) after the first dose, “CDC said. The United States is the most affected country in the world with more than 24 million COVID-19 cases and more than 4,00,000 deaths. As of January 23, the U.S. has administered more than 19 million doses of COVID-19 vaccines, the largest number in the world.
Read: COVID-19: May Halve Moderna USA vaccine doses to protect more people